Wittich, C., Ettich, J., Hertell, M., Roy, B. G., Xu, H. C., Floss, D. M., Lang, P. A., Scheller, J. (2025). An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108205